Patents by Inventor Garrett E. BERRY

Garrett E. BERRY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11981914
    Abstract: AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein are described. Also described are methods of administering the virus vectors and virus capsids to a cell or to a subject in vivo.
    Type: Grant
    Filed: September 25, 2023
    Date of Patent: May 14, 2024
    Assignee: Ginkgo Bioworks, Inc.
    Inventors: Daniel McCoy, Garrett E. Berry
  • Patent number: 11976096
    Abstract: The present disclosure provides recombinant AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the recombinant AAV capsid proteins. The disclosure also provides methods of administering the virus vectors and vims capsids of the disclosure to a cell or to a subject in vivo.
    Type: Grant
    Filed: September 26, 2023
    Date of Patent: May 7, 2024
    Assignee: Ginkgo Bioworks, Inc.
    Inventors: Daniel McCoy, Garrett E. Berry
  • Publication number: 20240067986
    Abstract: AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein are described. Also described are methods of administering the virus vectors and virus capsids to a cell or to a subject in vivo.
    Type: Application
    Filed: September 25, 2023
    Publication date: February 29, 2024
    Inventors: Daniel McCoy, Garrett E. Berry
  • Publication number: 20240059742
    Abstract: The present disclosure provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The disclosure also provides methods of administering the vims vectors and virus capsids of the disclosure to a cell or to a subject in vivo.
    Type: Application
    Filed: September 26, 2023
    Publication date: February 22, 2024
    Inventors: Daniel McCoy, Garrett E. Berry, James Kennon Smith
  • Patent number: 11905523
    Abstract: Provided herein are gene therapy compositions and methods for treating, preventing, and/or curing NPC1. More specifically, the disclosure provides Adeno-associated virus (AAV) vectors for delivery of nucleic acids and nucleic acids (including AAV transfer cassettes) for treating, preventing, and/or curing NPC1.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: February 20, 2024
    Assignee: Ginkgo Bioworks, Inc.
    Inventors: Daniel McCoy, Garrett E. Berry, David Dismuke
  • Publication number: 20240051998
    Abstract: The present disclosure provides recombinant AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the recombinant AAV capsid proteins. The disclosure also provides methods of administering the virus vectors and vims capsids of the disclosure to a cell or to a subject in vivo.
    Type: Application
    Filed: September 26, 2023
    Publication date: February 15, 2024
    Inventors: Daniel McCoy, Garrett E. Berry
  • Publication number: 20220064675
    Abstract: AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein are described. Also described are methods of administering the virus vectors and virus capsids to a cell or to a subject in vivo.
    Type: Application
    Filed: September 20, 2021
    Publication date: March 3, 2022
    Inventors: Daniel McCoy, Garrett E. Berry
  • Publication number: 20210371471
    Abstract: The present disclosure provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The disclosure also provides methods of administering the virus vectors and virus capsids of the disclosure to a cell or to a subject in vivo.
    Type: Application
    Filed: April 3, 2019
    Publication date: December 2, 2021
    Inventors: Daniel McCoy, Garrett E. Berry, James Kennon Smith
  • Publication number: 20210371469
    Abstract: The present disclosure provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein. The disclosure also provides methods of administering the vims vectors and vims capsids of the disclosure to a cell or to a subject in vivo.
    Type: Application
    Filed: April 3, 2019
    Publication date: December 2, 2021
    Inventors: Daniel McCoy, Garrett E. Berry
  • Publication number: 20210363191
    Abstract: The present disclosure provides recombinant AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the recombinant AAV capsid proteins. The disclosure also provides methods of administering the virus vectors and virus capsids of the disclosure to a cell or to a subject in vivo.
    Type: Application
    Filed: April 3, 2019
    Publication date: November 25, 2021
    Inventors: Daniel McCoy, Garrett E. Berry
  • Publication number: 20210115474
    Abstract: Provided herein are gene therapy compositions and methods for treating, preventing, and/or curing NPC1. More specifically, the disclosure provides Adeno-associated virus (AAV) vectors for delivery of nucleic acids and nucleic acids (including AAV transfer cassettes) for treating, preventing, and/or curing NPC1.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 22, 2021
    Inventors: Daniel MCCOY, Garrett E. BERRY, David DISMUKE